ERBB2 and breast cancer: Given the established role of EMT in breast cancer progression [19], deciphering the biological function of TGF-β signaling in trastuzumab resistance and metastasis of HER2 positive breast cancer will provide novel insights into molecular mechanism underlying multifaceted malignant phenotypes of breast cancer.